A predictive model for personalized therapeutic interventions in non-small cell lung cancer

Medicine & Life Sciences

• Non-Small Cell Lung Carcinoma 51%
• ErbB Receptors 41%
• Clinical Decision Support Systems 37%
• Decision Trees 35%
• Patient Selection 25%
• Histology 22%
• Smoking 20%
• Molecular Targeted Therapy 19%
• Support Vector Machine 17%
• Mutation 16%
• Protein-Tyrosine Kinases 13%
• Area Under Curve 11%
• Lung Neoplasms 11%
• Clinical Studies 10%
• Therapeutics 9%
• Neoplasms 9%
• Quality of Life 9%
• Physicians 9%
• Survival 8%
• Pharmaceutical Preparations 5%

Engineering & Materials Science

• Epidermal Growth Factor 100%
• Histology 56%
• Cells 56%
• Tumors 39%
• Decision trees 37%
• Personalized medicine 27%
• Support vector machines 15%
• Classifiers 13%